|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 23212703.5 (espacenet) (Federated) (European Patent Register), 20231128 | | Patent/reg. no. and date | DK/EP 4375659, 20250326 | | Publication date | 20240529 | | Priority no. and date | EP 22210027, 20221128 | | EP pub. no. and date |
EP 4375659 20240529 | | Effective date | | | Applicant/owner | Takeda Vaccines, Inc., 75 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | | | Inventor | SOMANADHAN, Brinda,
02139 Cambridge, US | | Representative | | | Opponent | | | IPC Class | G01N 30/88 (2006.01) | | Title | A METHOD FOR THE QUANTITATIVE DETERMINATION OF HUMAN SERUM ALBUMIN MONOMER IN VIRUS-CONTAINING PHARMACEUTICAL COMPOSITIONS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
